Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. MaxCyte Inc shares valued at $22,025 were sold by Johnston John Joseph on Mar 26 ’24. At $4.41 per share, Johnston John Joseph sold 5,000 shares. The insider’s holdings dropped to 120,583 shares worth approximately $0.5 million following the completion of this transaction.
Also, Johnston John Joseph sold 5,000 shares, netting a total of over 25,585 in proceeds. Following the sale of shares at $5.12 each, the insider now holds 120,583 shares.
Before that, Johnston John Joseph had sold 5,000 shares from its account. In a trade valued at $22,650, the Director traded MaxCyte Inc shares for $4.53 each. Upon closing the transaction, the insider’s holdings decreased to 5,000 shares, worth approximately $0.5 million.
As published in their initiating research note from Craig Hallum on November 29, 2023, MaxCyte Inc [MXCT] has been a Buy and the price target has been revised to $7. As of August 24, 2021, William Blair has initiated its “an Outperform” rating for MXCT. Earlier on August 24, 2021, Wedbush initiated its rating. Their recommendation was “an Outperform” for MXCT stock.
Analyzing MXCT Stock Performance
During the last five days, there has been a drop of approximately -4.63%. Over the course of the year, MaxCyte Inc shares have dropped approximately -12.34%. Shares of the company reached a 52-week high of $5.55 on 01/12/24 and a 52-week low of $3.85 on 03/12/24. A 50-day SMA is recorded $4.55, while a 200-day SMA reached $4.21. Nevertheless, trading volume fell to 0.86 million shares from 0.41 million shares the previous day.
Support And Resistance Levels for MaxCyte Inc (MXCT)
According to the 24-hour chart, there is a support level at 4.05, which, if violated, would cause prices to drop to 3.99. In the upper region, resistance lies at 4.23. The next price resistance is at 4.34. RSI (Relative Strength Index) is 40.94 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.14, which suggests the price will decrease in the coming days. Percent R is at 85.96%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
Is MaxCyte Inc subject to short interest?
Stocks of MaxCyte Inc saw a sharp steep in short interest on Mar 15, 2024 dropping by 50000.0 shares to 3.12 million. Data from Yahoo Finance shows that the short interest on Feb 15, 2024 was 3.17 million shares. A decline of -1.6% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 4.94 of the overall float, the days-to-cover ratio (short ratio) decline to 4.94.
